Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cerevel Therapeutics Holdings, Inc. - Common Stock
(NQ:
CERE
)
44.96
UNCHANGED
Last Price
Updated: 4:15 PM EDT, Jul 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cerevel Therapeutics Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Mid-Afternoon Market Update: US Stocks Mostly Flat; DiaMedica Therapeutics Shares Plunge
June 29, 2021
Toward the end of trading Tuesday, the Dow traded up 0.04% to 34,295.41 while the NASDAQ rose 0.13% to 14,518.98. The S&P traded flat at 4,290.65. The U.S. has the highest...
Via
Benzinga
Topics
Stocks
These 2 Nasdaq Biotechs Made Eye-Popping Moves Tuesday
June 29, 2021
You might not have heard of them, but one went up big while the other served up a massive disappointment.
Via
The Motley Fool
Topics
Stocks
S&P 500 Hits 4th-Straight Intraday High as Home Prices Surge
June 29, 2021
The major benchmarks are higher this afternoon, after a mixed start to today's session.
Via
Talk Markets
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 29, 2021
Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) stock moved upwards by 93.55% to $24.33 during Tuesday's regular session. As of 12:30 EST, this security is trading at...
Via
Benzinga
Here's Why Cerevel Therapeutics Stock Is Shooting Through the Roof Today
June 29, 2021
Positive topline results from the company's schizophrenia candidate were better than expected.
Via
The Motley Fool
Mid-Day Market Update: Gold Drops Over 1%; Cerevel Therapeutics Shares Spike Higher
June 29, 2021
Midway through trading Tuesday, the Dow traded up 0.37% to 34,411.60 while the NASDAQ fell 0.03% to 14,495.75. The S&P also rose, gaining 0.16% to 4,297.63. The U.S. has the...
Via
Benzinga
Topics
Stocks
35 Stocks Moving In Tuesday's Mid-Day Session
June 29, 2021
Gainers Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) shares jumped 111.5% to $26.58 after the company announced positive results from its Phase 1b clinical trial of CVL-231...
Via
Benzinga
Mid-Morning Market Update: Markets Mostly Higher; FactSet Research Reports Mixed Q3 Results
June 29, 2021
Following the market opening Tuesday, the Dow traded up 0.40% to 34,420.32 while the NASDAQ fell 0.10% to 14,486.23. The S&P also rose, gaining 0.14% to 4,296.59. The U.S. has...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 29, 2021
Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) shares moved upwards by 42.0% to $17.85 during Tuesday's pre-market session. The company's market cap stands at $2....
Via
Benzinga
Cerevel Therapeutics Stock Shoots Higher As Schizophrenia Treatment Tops Placebo On Antipsychotic Activity
June 29, 2021
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) has announced results from its Phase 1b trial of CVL-231 in adult patients with schizophrenia. CVL-231 was...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 18, 2021
June 18, 2021
Upgrades According to JP Morgan, the prior rating for Orion Engineered Carbons SA (NYSE:
Via
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
June 29, 2021
Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was...
Via
Benzinga
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
June 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 18, 2021
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) stock rose 21.47% to $5.26 during Friday's pre-market session. The company's market cap stands at $68.5 million....
Via
Benzinga
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
May 15, 2021
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the...
Via
Benzinga
Earnings Scheduled For May 17, 2021
May 17, 2021
Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter. • U.S. Well Services (NASDAQ:...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 21, 2021
Gainers Alterity Therapeutics (NASDAQ:ATHE) shares rose 17.59% to $1.47 during Wednesday's regular session. As of 12:31 EST, this security is trading at a volume of 55...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today